Navigation Links
New Incision-Less Procedure for REFLUX - Experts Consider it to Be Gold Standard for REFLUX
Date:10/26/2009

CHICAGO, Oct. 26 /PRNewswire/ --

    What:        A Chicago woman will be among the first in the country to
                 undergo a new incision-less, endoscopic procedure that could
                 get rid of Gastrointestinal Esophageal Reflux Disease (GERD)
                 forever.  The procedure, called TIF, is performed
                 transorally, through the mouth.  After navigating an
                 endoscope through the body, the doctor uses a device to
                 create a secure fold between the stomach and the esophagus
                 stopping the flow of acids into the esophagus.  Recent
                 studies show that the procedure is as effective as surgery
                 but without the long hospital stay and risk of complications.
                 In addition, TIF can reduce patients' dependency on daily
                 medication by 79 percent or more.

    Who:         Arun Ohri, M.D., of GI Solutions and a leading authority in
                 Gastrointestinal Esophageal Reflux Disease (GERD), will be
                 one of the first  to use a new, incision-free procedure for
                 GERD patients, will perform the incision-free surgery using
                 the new technology.  .

    When:        1 p.m. Wednesday, October 28

    Where:       Resurrection Medical Center, 7435 West Talcott, Chicago

    Background:  An estimated 60 million Americans are diagnosed with chronic
                 GERD, painful heartburn caused when stomach acid breaks
                 through what is supposed to be a one-way valve -- the lower
                 esophageal sphincter (LES) -- and reverses into the esophagus.
                 GERD increases risk of cancer of the esophagus and can cause
                 damage due to inhalation of stomach acid. While many patients
                 are prescribed daily medications for treatment, they are
                 sometimes ineffective. In addition, new research indicates
                 that continued drug therapy may cause calcium depletion,
                 contributing to osteoporosis.

                 GERD has long been associated with obesity. Recent studies
                 also show that reflux sufferers are more prone to have sleep
                 deprivation. Anthony DiMarina Jr., lead author of a study on
                 sleep medication reported in the September issue of Clinical
                 Gastroenterology and Hepatology says, "As many as 15 percent
                 to 30 percent of patients with disturbed sleep may have
                 undiagnosed GERD."

SOURCE GI Solutions


'/>"/>
SOURCE GI Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AbbeyMoor Medical Receives Category I CPT(R) Code for The Spanner(TM) Prostatic Stent Procedure
2. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
3. Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries
4. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
5. NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology
6. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
7. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
8. New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
9. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
10. Novare Announces Successful Series of Single Port Lap Band Procedures With RealHand(R) High Dexterity Instruments
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):